STAT1h
FDA scolds Merz over ‘misleading’ Instagram posts featuring interior designer Nate Berkus
For a fifth time this year, the FDA has scolded a pharma company for misleading marketing, this time over a Merz ...
Investor ideas4h
Biotech and Medical Tech Stocks and the Hunt for Cancer Treatments
According to a recent article in Biospace ,"The solid tumors market size reached a value of US$ 170.3 Billion in 2023. Looking forward, the market is expected to reach US$ 375.4 Billion by 2034, ...
STAT6h
Merck licenses Chinese cancer drug, searching for next Keytruda blockbuster
In a move to safeguard the company’s dominant position in cancer, Merck said Thursday it will license a new cancer drug from ...
Bangladesh Sangsbad Sangstha7h
Rush of patients, manpower shortage weigh on RpMCH, disrupting medical services
By Md Mamun Islam RANGPUR, Nov 14, 2024 (BSS) - Rush of patients, manpower shortage and unplanned development in the previous ...
Acrivon Therapeutics, Inc.: Promising Advancements and Strong Buy Rating Backed by Innovative Pipeline and Solid Financial Position
TD Cowen analyst Marc Frahm has maintained their bullish stance on ACRV stock, giving a Buy rating today. Marc Frahm has given his Buy rating ...